After historic levels of private equity (PE) deal-making in 2021 and 2022, activity dipped in the first half of this year as firms dealt with debt service costs and other economic challenges—but that doesn’t necessarily mean your organization is safe from the PE disruption.
PE deals are expected to rise though in the second half of the year and into 2024 as the debt market recovers and inflationary pressures settle.
This just goes to show that PE’s presence in healthcare isn’t diminishing anytime soon, even if the level of activity doesn’t return to the record-breaking highs during the peak of the COVID-19 pandemic, Health Leaders Media reports.
CFOs have decidedly realized that if you can’t fight PE, you might as well partner if necessary, so reading the market and recognizing the ebbs and flows of PE is critical for providers who are considering partnerships with firms. Read more.
